Azithromycin
Rank #400 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$22.2M
Total Cost
3,009,458
Total Claims
$22.2M
Total Cost
80,499
Prescribers
$7
Cost per Claim
2,353,051
Beneficiaries
3,138,026
30-Day Fills
$276
Avg Cost/Provider
37
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$22.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $22.2M total
🔎 Data Overview
At $7.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Azithromycin
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Triet Nguyen | Ophthalmology | Westminster, CA | 229 | $82K |
| 2 | Jon Michel | Pulmonary Disease | Peoria, IL | 2,041 | $41K |
| 3 | Gary Schafer | Pulmonary Disease | Forest City, NC | 1,269 | $31K |
| 4 | Gregg Berdy | Ophthalmology | Saint Louis, MO | 57 | $30K |
| 5 | Jesse Romeu-Velez | Pulmonary Disease | Winter Haven, FL | 720 | $29K |
| 6 | Kapilkumar Patel | Pulmonary Disease | Tampa, FL | 644 | $23K |
| 7 | Phillip Haddad | Pulmonary Disease | Shawnee, OK | 794 | $19K |
| 8 | Ashok Mittal | Pulmonary Disease | St Petersburg, FL | 463 | $19K |
| 9 | Mrunal Patel | Pulmonary Disease | Maywood, IL | 1,273 | $18K |
| 10 | Robert Tanaka | Pulmonary Disease | Modesto, CA | 709 | $17K |
| 11 | Peter Wong | Ophthalmology | Rockville Centre, NY | 38 | $14K |
| 12 | Derek Byers | Pulmonary Disease | Saint Louis, MO | 403 | $13K |
| 13 | David Oliver | Pulmonary Disease | Easton, MD | 682 | $13K |
| 14 | Edwin Valentin | Family Practice | Bayamon, PR | 1,703 | $13K |
| 15 | Yuh-Chin Huang | Pulmonary Disease | Durham, NC | 518 | $13K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 397 | Ravulizumab-Cwvz (Ultomiris) | $23.1M | 428 |
| 398 | Roflumilast (Roflumilast) | $22.8M | 97,022 |
| 399 | Romosozumab-Aqqg (Evenity (2 Syringes)) | $22.3M | 9,087 |
| 400 | Azithromycin (Azithromycin) | $22.2M | 3,009,458 |
| 401 | Torsemide (Torsemide) | $22.2M | 971,579 |
| 402 | Doxepin Hcl (Doxepin Hcl) | $22.2M | 371,255 |
| 403 | Loteprednol Etabonate (Loteprednol Etabonate) | $22.1M | 85,761 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology